GALAXIES PHARMACEUTICALS OÜ

Media page and news feed
?
Bioloogiliste ravimite tootmine nõuab täpsust, kontrolli ja paindlikkust — iga samm peab tagama ohutuse ja toimeainete stabiilsuse. Pakutav lahendus ühendab kaa

Usaldusväärne steriilne ja skaleeritav bioloogiliste ravimite tootmine

Bioloogiliste ravimite tootmine nõuab täpsust, kontrolli ja paindlikkust — iga samm peab tagama ohutuse ja toimeainete stabiilsuse. Pakutav lahendus ühendab kaasaegse puhta infrastruktuuri ja teaduslähtelised protsessid, et toimetada steriilseid ja skaleeritavaid biotehnoloogilisi lahendusi eri annustamisvormides. Süsteemse kvaliteedijuhtimise ja range regulatiivse vastavusega tagatakse tulemus, mis toetab turule jõudmist ja patsiendi ohutust.

Kellele sobib

Teenustus on mõeldud farmaatsiaettevõtetele, biotehnoloogia start-up’idele, kliiniliste uuringute partneritele ja kontrakttootjatele, kes otsivad usaldusväärset partnerit biotehnoloogiline tootmine ning steriilne ravimite tootmine projektide elluviimiseks. Eraldi väärtust pakutakse neile, kes vajavad tootmist eri annustamisvormides — vaadelda saab nii vedelikku, lüofilisaati, süstlaid, vials’e kui ka kaudseid manustamisviise.

Mida pakutakse

  • Skaleeritav tootmislahendus: protsessid, mis skaleeruvad laboriskaalalt kliinilise ja kommertstootmise tasemele.
  • Steriilne ravimite tootmine: aseptilised fill-finish protsessid, lüofiliseerimine ja ranged puhtusstandardid.
  • Annustamisvormide tootmine: vials, pre-filled syringes, cartridged ja muud kliendi nõuetele vastavad formaadid.
  • Protsessiarendus ja tehnikaülekanne: protsessi optimeerimine, dokumentatsioon ja sujuv üleminek tootmisse.
  • Kvaliteedi- ja regulatiivtugi: GMP, validaalsus, partii-vastavus ja analüütilised teenused kogu elutsükli jooksul.

Peamised eelised

  • Kiirem turule jõudmine: valmis infrastruktuur ja kogemus vähendavad ajakulu protsessi valideerimisel ja skaaleerimisel.
  • Riskide vähendamine: range keskkonnakontroll ja andmepõhine kvaliteedijuhtimine tagavad toodete järjepidevuse.
  • Kuluefektiivsus: optimeeritud tootmisvood ja modulaarne lähenemine alandavad kulusid ilma kvaliteeti ohverdamata.
  • Paindlikkus: sobiv mitmeannustamisvormi tootmiseks ja erinevate kliiniliste faaside toetamiseks.
  • Patsiendi ohutus ja toote terviklikkus: kogu elutsükli vältel rakendatakse häid tootmistavasid ja jälgitavust.

Mis teeb eriliseks

Erinevuseks on integreeritud lähenemine, kus teaduslik protsessiarendus sulandub kaasaegse tootmisinfrastruktuuriga: puhtad ruumid, automatiseeritud seadmed ja range kvaliteedikontroll. Pakutakse ka andmehalduse lahendusi ja regulaatori nõuetele vastavat dokumentatsiooni, mis lihtsustab auditite läbiviimist ning tehnikaülekannet partneritele. Selle tulemuseks on usaldusväärne partnerlus, mis kaitseb nii investeeringut kui lõppkasutajat.

Keskmisest kõrgemal tasemel bioloogiliste ja biotehnoloogiliste lahenduste elluviimine annab kindluse, et tootmine vastab nii teaduslikele kui regulatiivsetele ootustele. Võta ühendust, et arutada konkreetseid vajadusi ja kujundada skaleeritav tootmisplaan, mis toetab ärilisi eesmärke.

Comments (0)


Are you sure you want to delete this article?

Dropdown

all articles

Reliable sterile and scalable production of biological medicinal products

The production of biological medicines   requires precision, control and flexibility - every step must ensure safety and the stability of active substances. The
ssb.ee
The production of biological medicines requires precision, control and flexibility - every step must ensure safety and the stability of active substances. The proposed solution combines modern clean infrastructure and research-based processes to deliver sterile and scalable biotechnological solutions in different forms of dosage. Systematic quality management and strict regulatory compliance ensure a result that supports market entry and patient safety. For whom Service is suitable for pharmaceutical companies, biotechnology start-ups, clinical trial partners and contrast manufacturers

GMP-level gene vector production: purity, stability and regulatory certainty for placing gene therapy medicinal products on the market

Overview   GMP compliant production  focuses on the production of high-quality gene vectors and gene therapy medicinal products that support both clinical trial
ssb.ee
Overview GMP compliant production focuses on the production of high-quality gene vectors and gene therapy medicinal products that support both clinical trials and commercial production. The services are designed to develop genetic treatments by providing a scalable, safe and reproducible production solution that reduces development risks and speeds up the time line to reach the market. Who benefits? The services are suitable for biotechnology companies, pharmaceutical companies, research laboratories and start-up teams that require reliable production of gen vectors for the clinical

Complete laboratory analysis and development of pharmaceutical formulations - reliable quality control and validated production processes

Connected with quality, repeatability and regulatory compliance.  Complete laboratory analysis and development of adapted pharmaceutical formulations ensure tha
ssb.ee
Connected with quality, repeatability and regulatory compliance. Complete laboratory analysis and development of adapted pharmaceutical formulations ensure that the performance and safety of the product meet both the requirements of the clinical and manufacturing environment. What service covers Provides comprehensive laboratory analysis and testing , extensive quality control and analysis and targeted medical formulations development . Work also includes the validation of production processes in order to confirm the replicability of processes and support regulatory approval.

Complete pharmaceutical production - fast pharmaceutical product development and production of biological medicinal products that meet GMP requirements

Healthy pharmaceutical production  combines scientific precision and industrial performance in order to bring drug development from the idea to the clinical pha
ssb.ee
Healthy pharmaceutical production combines scientific precision and industrial performance in order to bring drug development from the idea to the clinical phase and to the market faster and safer. The services cover the entire value chain: pharmaceutical product development, formulations, production of biological medicines and full quality control and analysis - all according to GMP compliant production . What does this mean for production and development? Integrated approach reduces transition, shorter timetables ensure lower risk and better cost-effectiveness. In combination with a

Are you sure you want to delete this article?

Loader

Loader

App Ad

Scorestorybook Chrome extension

The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.